Reassessing formulary changes: interpreting real-world evidence on liposomal bupivacaine

Regional Anesthesia & Pain Medicine 2026

View at publisher
Authors: Tuhin Mistry, Abhijit Sukumaran Nair
DOI: 10.1136/rapm-2025-107500
Cited by: 1
References: 6

Abstract

We read with interest the research letter by Patel et al evaluating outcomes before and after the removal of liposomal bupivacaine from a health-system formulary for patients undergoing video-assisted thoracoscopic (VATS) wedge resection.[1][1] The authors should be commended for leveraging a real-

Fields of Study & Subjects

Anesthesia and Pain Management Sympathectomy and Hyperhidrosis Treatments Cancer Stress Anesthesia and Immune Response

Publication details

Journal / source
Regional Anesthesia & Pain Medicine
Publisher
BMJ
Pages
rapm–2025
Publication date
6 January 2026
Language
EN